Key facts
- It has raised $31.0M; the latest was Accelerator/Incubator in Sep 2024.
- Notable investors include Meltwind Advisory, Lauder Partners, Formic Ventures, H&S Ventures, LifeSpan Vision Ventures — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for NaNotics
- ·The full record, as it builds
Funding rounds
No funding rounds for NaNotics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NaNotics
Developer of a nanomedical platform designed for treating major diseases by removing specific molecules from the bloodstream. The company's platform uses nanoparticles injected like a drug to quickly and safely target and deplete disease-causing molecules within minutes, enabling physicians to offer patients a new and safe treatment modality.
- Sector
- Healthcare
- HQ
- Mill Valley, CA, United States
- Founded
- 2015
- Employees
- 7
- Website
- nanotics.com/
- Ownership
- Privately Held (backing)
NaNotics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NaNotics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NaNotics in its N-PORT filings yet. We sweep new filings monthly.